Riskpilot← Back to searchSign inGet full accessEmeriti Bio AB
ABActiveOrg 5590399092Pepparedsleden 1Research and experimental development on natural sciences and engineering · NACE 7210Est. 20150 employees
Revenue 2025
SEK 1,4M
-62% vs 2024
EBITDA margin
16.9%
-41% vs 2024
Equity ratio
58.1%
Financial strength
Net profit 2025
SEK 185K
-43% vs 2024
| Revenue | SEK 1,4M | -62% |
| EBITDA | SEK 242K | -41% |
| Net profit | SEK 185K | -43% |
| Total assets | SEK 1,3M | -20% |
| Equity | SEK 775K | -29% |
| Employees | 0 | — |
Legal name
Emeriti Bio AB
Org number
5590399092
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
9 december 2015
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firmanbeträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva utveckling av substanser och beredningar som är kandidater för fullskalig läkemedelsutveckling samt därmed förenlig konsultverksamhet.
Address
Pepparedsleden 1
Email
jan.fryklund@emeritibio.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 295 | 6 197 | 1 230 | 3 770 | 1 434 |
| Staff expenses | — | — | −73 | −2 556 | −462 |
| EBITDA | 850 | 2 658 | 558 | 412 | 242 |
| Depreciation & amort. | −0 | −0 | −2 | −11 | −11 |
| EBIT | 850 | 2 658 | 556 | 401 | 231 |
| Net financials | — | −1 | 11 | 12 | 2 |
| Profit before tax | 850 | 2 658 | 763 | 412 | 233 |
| Tax | −175 | −552 | −159 | −88 | −48 |
| Net profit | 675 | 2 106 | 604 | 324 | 185 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 425 | 3 669 | 1 723 | 1 674 | 1 334 |
| Equity | 725 | 2 156 | 960 | 1 090 | 775 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 504 | 1 317 | 763 | 584 | 560 |
| Total debt | 504 | 1 317 | 763 | 584 | 560 |
EBITDA margin
16.9%
This company
15.8%
Market median
+7% vs market
20212025
Equity ratio
58.1%
This company
38.2%
Market median
+52% vs market
20212025
Return on equity
23.9%
This company
18.4%
Market median
+30% vs market
20212025
Net profit margin
12.9%
This company
8.1%
Market median
+59% vs market
20212025
Asset turnover
1.07×
This company
1.12×
Market median
+4% vs market
20212025
Debt / equity
0.72×
This company
0.62×
Market median
+16% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
NG | Audit | 2021 |
JF Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
| Chairman | 2021 | |
| Board of Directors | 2021 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2021 | |
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Emeriti Bio AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Gustaf Peter Gårdström | Audit | 0 companies |
| Jan Folke Fryklund | Chief Executive Officer | 0 companies |
| Björn-Gabriel Morgan Wallmark | Chairman | 0 companies |
| Tomas Fex | Board of Directors | 0 companies |
| Udo Andreas Bauer | Board of Directors | 0 companies |
| Lennart Bengt Olof Ohlsson | Deputy Board Member | 0 companies |
| Nils David Gustafsson | Board of Directors | 0 companies |
| Lars Hugo Gustafsson | Board of Directors | 0 companies |